AJMC January 1, 2025
Edgardo S. Santos, MD, FACP, FASCO, highlighted how liquid biopsies are transforming lung cancer care by enabling faster, less invasive diagnostics, with key applications in early detection, predictive biomarker identification, treatment response monitoring, resistance mechanism assessment, and minimal residual disease detection.
In an interview, Edgardo S. Santos, MD, FACP, FASCO, a hematologist and medical oncologist at the Oncology Institute of Hope and Innovation, highlighted how liquid biopsies are revolutionizing the early detection and management of lung cancer. He explained that liquid biopsies minimize the need for invasive procedures like surgical biopsies, which can lead to complications such as lung collapse. Additionally, the turnaround time for results has significantly improved, now taking just 3 to 5 days compared with 10 days...
Today's Sponsors
Today's Sponsor